Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity

被引：66
|
作者：
Majumdar, Papiya [1 ]
Bathula, Chandramohan [2 ]
Basu, Suparna M. [1 ]
Das, Subhendu K. [1 ]
Agarwal, Rahul [3 ]
Hati, Santanu [2 ]
Singh, Ashutosh [3 ]
Sen, Subhabrata [2 ]
Das, Benu Brata [1 ]
机构：
[1] Indian Assoc Cultivat Sci, Dept Phys Chem, Mol Biol Lab, Kolkata 700032, India
[2] Shiv Nadar Univ, Dept Chem, Gautam Buddha Nagar 201314, Uttar Pradesh, India
[3] Shiv Nadar Univ, Dept Life Sci, Gautam Buddha Nagar 201314, Uttar Pradesh, India
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 102卷
基金：
英国惠康基金;
关键词：
Topoisomerase I; Thiohydantoin; Hydantoin; Methylfuro[3,4-c]pyridine-3,4(1H,5H)-dione; Camptothecin; Leishmania bi-subunit topoisomerase I; DNA TOPOISOMERASES; LEISHMANIA; SUBUNIT; CAMPTOTHECIN; HYDANTOIN; TDP1; DISCOVERY; REPAIR;
D O I：
10.1016/j.ejmech.2015.08.032
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：540 / 551
页数：12
相关论文
共 50 条
  • [1] Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)-Topoisomerase I (Top1) Inhibitors
    Trung Xuan Nguyen
    Morrell, Andrew
    Conda-Sheridan, Martin
    Marchand, Christophe
    Agama, Keli
    Bermingam, Alun
    Stephen, Andrew G.
    Chergui, Adel
    Naumova, Alena
    Fisher, Robert
    O'Keefe, Barry R.
    Pommier, Yves
    Cushman, Mark
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (09) : 4457 - 4478
  • [2] Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
    Xu, Yang
    Her, Chengtao
    BIOMOLECULES, 2015, 5 (03): : 1652 - 1670
  • [3] Design, synthesis and evaluation of dibenzo[c,h][1,6]naphthyridines as Top1 inhibitors and potential anticancer agents
    Kiselev, Evgeny
    Dexhemier, Thomas
    Pommier, Yves
    Cushman, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [4] Synthesis and identification of quinoline derivatives as topoisomerase I inhibitors with potent antipsoriasis activity in an animal model
    Zhang, Wen-Jin
    Li, Peng-Hui
    Zhao, Min-Cong
    Gu, Yao-Hao
    Dong, Chang-Zhi
    Chen, Hui-Xiong
    Du, Zhi-Yun
    BIOORGANIC CHEMISTRY, 2019, 88
  • [5] Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I
    Guo, Wei
    Miao, Zhenyuan
    Sheng, Chunquan
    Yao, Jianzhong
    Feng, Hao
    Zhang, Wannian
    Zhu, Lingjian
    Liu, Wenfeng
    Cheng, Pengfei
    Zhang, Jing
    Che, Xiaoying
    Wang, Wenya
    Luo, Chuan
    Xu, Yulan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (06) : 2223 - 2228
  • [6] Synthesis and Biological Evaluation of Novel Homocamptothecins Conjugating with Dihydropyrimidine Derivatives as Potent Topoisomerase I Inhibitors
    Zhu, Lingjian
    Cheng, Pengfei
    Lei, Ning
    Yao, Jianzhong
    Sheng, Chunquan
    Zhuang, Chunlin
    Guo, Wei
    Liu, Wenfeng
    Zhang, Yongqiang
    Dong, Guoqiang
    Wang, Shengzhang
    Miao, Zhenyuan
    Zhang, Wannian
    ARCHIV DER PHARMAZIE, 2011, 344 (11) : 726 - 734
  • [7] Design and Synthesis of Arylnaphthalene Lignan Lactone Derivatives as Potent Topoisomerase Inhibitors
    Chen, Wang
    Feng, Zili
    Hu, Daihua
    Meng, Jin
    MEDICINAL CHEMISTRY, 2021, 17 (08) : 856 - 865
  • [8] The NEDD8 inhibitor pevonedistat blocks the repair of topoisomerase I (TOP1)-induced replication damage and synergizes with TOP1 inhibitors.
    Sun, Yilun
    Baechler, Andrea
    Factor, Valentina
    Okamoto, Kanako
    Pommier, Yves
    CANCER RESEARCH, 2021, 81 (13)
  • [9] Design, synthesis and evaluation of phthalazinone thiohydantoin-based derivative as potent PARP-1 inhibitors
    Zhong, Yi
    Meng, Ying
    Xu, Xi
    Zhao, Lulu
    Li, Zhiyu
    You, Qidong
    Bian, Jinlei
    BIOORGANIC CHEMISTRY, 2019, 91
  • [10] Design, synthesis, and biological evaluation of harmine derivatives as topoisomerase I inhibitors for cancer treatment
    Guo, Ya-Li
    Yu, Jing-Wen
    Cao, Yan
    Cheng, Ke-Xin
    Dong-Zhi, Suo-Nan-Mu
    Zhang, Yan-Fei
    Ren, Qing-Jia
    Yin, Yong
    Li, Cao-Long
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 265
12345